Radiotherapy Guidelines for Spinal Meningioma
Primary Treatment Recommendation
Complete surgical resection including removal of the dural attachment is the treatment of choice for all symptomatic spinal meningiomas, and radiotherapy is NOT routinely indicated after gross total resection of benign (WHO grade I) lesions. 1, 2
Indications for Radiotherapy
Post-Operative Adjuvant Radiotherapy
Adjuvant radiotherapy is indicated in the following specific scenarios:
Incomplete resection of benign (WHO grade I) spinal meningioma: Postoperative radiotherapy with doses ≥50 Gy improves local control and progression-free survival from <40% to 70% at 10 years 3, 2
WHO grade II (atypical) meningiomas with subtotal resection: External beam radiation therapy is recommended with doses of 45-54 Gy regardless of extent of resection 4, 3, 5
WHO grade III (anaplastic/malignant) meningiomas: Postoperative radiotherapy with doses of 45-54 Gy is recommended regardless of extent of resection 4, 3
Recurrent tumors after prior complete resection: Radiotherapy should be performed as adjuvant therapy for early recurrence following total resection 2
Observation After Complete Resection
- WHO grade I meningiomas following gross total resection: A watch-and-wait strategy with MRI surveillance every 6-12 months is recommended, as up to 20% may recur within 25 years 3, 1, 6
Recommended Dose and Fractionation
Conventional External Beam Radiotherapy
The standard radiotherapy regimen for spinal meningioma is:
Dose range: 50-55 Gy in conventional fractionation (1.8-2.0 Gy per fraction) prescribed to the reference point 4
Dose escalation: Increases to 60 Gy should only be considered in exceptional circumstances such as WHO grade III meningiomas 4
Treatment schedule: All fields treated daily, 5 days per week 4
Dose-response relationship: A dose-dependent effect exists with a cut-off point of ≥53 Gy, improving 5-year progression-free survival from 17% to 63% in incompletely resected malignant meningiomas 4
Target Volume Definition
Gross Tumor Volume (GTV): Defined as macroscopic visible disease including the previous tumor bed based on pre- and post-operative contrast-enhanced T1-weighted MR sequences 4
Planning margins: 0.5-1.0 cm between GTV and planning target volume for benign and atypical meningiomas; 1.0-1.5 cm for anaplastic meningiomas 4
Inclusion of dural tail: Radiotherapy should generally include the dural tail and any abnormal bone on radiology 4
Stereotactic Radiosurgery (SRS) Considerations
When to Use SRS
Stereotactic radiosurgery is appropriate for select spinal meningiomas meeting specific criteria:
Small tumor size: SRS is most effective for tumors <3-3.5 cm in maximum diameter 6, 7
Residual or recurrent disease: SRS is particularly useful for residual or recurrent meningiomas after prior surgery 6, 7
Skull base locations: While the evidence primarily addresses intracranial skull base meningiomas (cavernous sinus, C-P angle), SRS has shown excellent 5-year tumor control rates >90% for benign meningiomas in these difficult surgical locations 4, 7
SRS vs. Fractionated Stereotactic Radiotherapy (SRT)
SRS (single fraction): Appropriate for smaller lesions with adequate distance from critical structures, achieving >90% 5-year tumor control 7
Fractionated SRT: Useful for larger meningiomas (>3-3.5 cm) and those closely approximating critical structures such as the spinal cord, with toxicity equivalent to radiosurgery despite treating more complicated volumes 7
Hypofractionated SRT (HSRT): Delivered in ≤5 fractions with dose per fraction ≥5 Gy, represents a middle ground between single-fraction SRS and conventional fractionation 8
Critical Pitfalls to Avoid
Do not routinely irradiate completely resected WHO grade I spinal meningiomas: The evidence shows observation is appropriate after gross total resection of benign lesions 3, 1
Do not use doses <50 Gy for incompletely resected lesions: Lower doses are associated with inferior local control, particularly <53 Gy 4, 3
Do not delay radiotherapy for high-grade lesions: WHO grade III meningiomas require prompt adjuvant radiotherapy regardless of extent of resection 4, 3
Do not assume all spinal meningiomas require radiotherapy: The indication remains controversial for incompletely resected benign grade I meningiomas, and treatment decisions should weigh the risk of recurrence against potential radiation toxicity 4
Long-Term Surveillance
Annual MRI surveillance for at least 10 years is mandatory given the risk of late recurrences, with some benign meningiomas recurring up to 25 years after initial treatment 4, 1, 6
Somatostatin receptor (SSTR) PET imaging may be useful in distinguishing tumor recurrence from post-treatment changes when conventional MRI is equivocal 6